Gossamer Bio Inc. (GOSS) Tops Q3 EPS by 5c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q3 EPS of ($0.21), $0.05 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target